Literature DB >> 15147561

Tethered ligand-derived peptides of proteinase-activated receptor 3 (PAR3) activate PAR1 and PAR2 in Jurkat T cells.

Kristina K Hansen1, Mahmoud Saifeddine, Morley D Hollenberg.   

Abstract

Proteinase-activated receptors (PARs) can activate a number of signalling events, including T-cell signal-transduction pathways. Recent data suggest that the activation of PARs 1, 2 and 3 in Jurkat T-leukaemic cells induces tyrosine phosphorylation of the haematopoietic signal transducer protein, VAV1. To activate the PARs, this study used the agonist peptides SFLLRNPNDK, SLIGKVDGTS and TFRGAPPNSF, which are based on the sequences of the tethered ligand sequences of human PARs 1, 2 and 3, respectively. Here, we show that peptides based on either the human or murine PAR(3)-derived tethered ligand sequences (TFRGAP-NH(2) or SFNGGP-NH(2)) do not activate PAR(3), but rather activate PARs 1 and 2, either in Jurkat or in other PAR-expressing cells. Furthermore, whilst thrombin activates only Jurkat PAR(1), trypsin activates both PARs 1 and 2 and also disarms Jurkat PAR(1) for thrombin activation. We conclude therefore that in Jurkat or related T cells, signalling via PARs that can affect VAV1 phosphorylation is mediated via PAR 1 or 2, or both, and that distinct serine proteinases may potentially differentially affect T-cell function in the settings of inflammation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15147561      PMCID: PMC1782474          DOI: 10.1111/j.1365-2567.2004.01870.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  26 in total

Review 1.  Protease-activated receptors in inflammation, neuronal signaling and pain.

Authors:  N Vergnolle; J L Wallace; N W Bunnett; M D Hollenberg
Journal:  Trends Pharmacol Sci       Date:  2001-03       Impact factor: 14.819

Review 2.  International Union of Pharmacology. XXVIII. Proteinase-activated receptors.

Authors:  Morley D Hollenberg; Steven J Compton
Journal:  Pharmacol Rev       Date:  2002-06       Impact factor: 25.468

Review 3.  VAV proteins as signal integrators for multi-subunit immune-recognition receptors.

Authors:  Martin Turner; Daniel D Billadeau
Journal:  Nat Rev Immunol       Date:  2002-07       Impact factor: 53.106

4.  A polymorphic protease-activated receptor 2 (PAR2) displaying reduced sensitivity to trypsin and differential responses to PAR agonists.

Authors:  S J Compton; J A Cairns; K J Palmer; B Al-Ani; M D Hollenberg; A F Walls
Journal:  J Biol Chem       Date:  2000-12-15       Impact factor: 5.157

5.  Signalling pathways induced by protease-activated receptors and integrins in T cells.

Authors:  Rachel Bar-Shavit; Miriam Maoz; Yin Yongjun; Maya Groysman; Idit Dekel; Shulamit Katzav
Journal:  Immunology       Date:  2002-01       Impact factor: 7.397

6.  Proteinase activated receptor 2: Role of extracellular loop 2 for ligand-mediated activation.

Authors:  B Al-Ani; M Saifeddine; A Kawabata; M D Hollenberg
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

7.  Role of thrombin signalling in platelets in haemostasis and thrombosis.

Authors:  G R Sambrano; E J Weiss; Y W Zheng; W Huang; S R Coughlin
Journal:  Nature       Date:  2001-09-06       Impact factor: 49.962

Review 8.  Thrombin signalling and protease-activated receptors.

Authors:  S R Coughlin
Journal:  Nature       Date:  2000-09-14       Impact factor: 49.962

9.  Proteinase-activated receptor 2 (PAR(2)): development of a ligand-binding assay correlating with activation of PAR(2) by PAR(1)- and PAR(2)-derived peptide ligands.

Authors:  B Al-Ani; M Saifeddine; A Kawabata; B Renaux; S Mokashi; M D Hollenberg
Journal:  J Pharmacol Exp Ther       Date:  1999-08       Impact factor: 4.030

10.  Glycosylation and the activation of proteinase-activated receptor 2 (PAR(2)) by human mast cell tryptase.

Authors:  S J Compton; B Renaux; S J Wijesuriya; M D Hollenberg
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

View more
  27 in total

Review 1.  Proteinase-activated receptors in the lower urinary tract.

Authors:  James D Moffatt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-02-10       Impact factor: 3.000

Review 2.  Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more.

Authors:  R Ramachandran; M D Hollenberg
Journal:  Br J Pharmacol       Date:  2007-12-03       Impact factor: 8.739

Review 3.  Biased signalling and proteinase-activated receptors (PARs): targeting inflammatory disease.

Authors:  M D Hollenberg; K Mihara; D Polley; J Y Suen; A Han; D P Fairlie; R Ramachandran
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

Review 4.  Proteinases, their receptors and inflammatory signalling: the Oxford South Parks Road connection.

Authors:  M D Hollenberg
Journal:  Br J Pharmacol       Date:  2015-03-17       Impact factor: 8.739

5.  Thrombin regulates the metastatic potential of human rhabdomyosarcoma cells: distinct role of PAR1 and PAR3 signaling.

Authors:  Marcin Wysoczynski; Rui Liu; Magda Kucia; Justyna Drukala; Mariusz Z Ratajczak
Journal:  Mol Cancer Res       Date:  2010-05-04       Impact factor: 5.852

6.  Leucocyte cytokines dominate platelet cytokines overtime in non-leucoreduced platelet components.

Authors:  Chaker Aloui; Tahar Chakroun; Antoine Prigent; Saloua Jemni-Yacoub; Fabrice Cognasse; Sandrine Laradi; Olivier Garraud
Journal:  Blood Transfus       Date:  2016-09-08       Impact factor: 3.443

7.  Cleavage of protease-activated receptors on an immortalized oral epithelial cell line by Porphyromonas gingivalis gingipains.

Authors:  Rodrigo A Giacaman; Anil C Asrani; Karen F Ross; Mark C Herzberg
Journal:  Microbiology (Reading)       Date:  2009-07-16       Impact factor: 2.777

8.  Protease activated receptors 1 and 4 sensitize TRPV1 in nociceptive neurones.

Authors:  Vittorio Vellani; Anna M Kinsey; Massimiliano Prandini; Sabine C Hechtfischer; Peter Reeh; Pier C Magherini; Chiara Giacomoni; Peter A McNaughton
Journal:  Mol Pain       Date:  2010-09-27       Impact factor: 3.395

9.  Enhanced effector function of CD8(+) T cells from healthy controls and HIV-infected patients occurs through thrombin activation of protease-activated receptor 1.

Authors:  Amanda Hurley; Mindy Smith; Tatiana Karpova; Rebecca B Hasley; Natalya Belkina; Stephen Shaw; Nariman Balenga; Kirk M Druey; Erin Nickel; Beverly Packard; Hiromi Imamichi; Zonghui Hu; Dean Follmann; James McNally; Jeanette Higgins; Michael Sneller; H Clifford Lane; Marta Catalfamo
Journal:  J Infect Dis       Date:  2012-11-29       Impact factor: 5.226

10.  Emerging roles of PAR-1 and PAFR in melanoma metastasis.

Authors:  Vladislava O Melnikova; Gabriel J Villares; Menashe Bar-Eli
Journal:  Cancer Microenviron       Date:  2008-02-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.